223 related articles for article (PubMed ID: 11842276)
1. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
Lamberts R; Brunner G; Solcia E
Digestion; 2001; 64(4):205-13. PubMed ID: 11842276
[TBL] [Abstract][Full Text] [Related]
2. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
3. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
Eissele R; Brunner G; Simon B; Solcia E; Arnold R
Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
[TBL] [Abstract][Full Text] [Related]
4. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
Rindi G; Fiocca R; Morocutti A; Jacobs A; Miller N; Thjodleifsson B;
Eur J Gastroenterol Hepatol; 2005 May; 17(5):559-66. PubMed ID: 15827447
[TBL] [Abstract][Full Text] [Related]
6. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
7. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
8. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
Klinkenberg-Knol EC; Nelis F; Dent J; Snel P; Mitchell B; Prichard P; Lloyd D; Havu N; Frame MH; Romàn J; Walan A;
Gastroenterology; 2000 Apr; 118(4):661-9. PubMed ID: 10734017
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group.
Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Thor K; Andersson A; Hattlebakk J; Havu N; Janatuinen E; Levander K; Liedman B; Nyström P
Gastroenterology; 1999 Aug; 117(2):319-26. PubMed ID: 10419912
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
11. Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats.
Hagiwara T; Mukaisho K; Ling ZQ; Sakano T; Sugihara H; Hattori T
Dig Dis Sci; 2007 Apr; 52(4):988-94. PubMed ID: 17342392
[TBL] [Abstract][Full Text] [Related]
12. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
[TBL] [Abstract][Full Text] [Related]
13. [Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa. Preliminary results].
Cadiot G; Vissuzaine C; Pospai D; Ruszniewski P; Potet F; Mignon M
Gastroenterol Clin Biol; 1995 Oct; 19(10):811-7. PubMed ID: 8566561
[TBL] [Abstract][Full Text] [Related]
14. Safety profile of the proton-pump inhibitors.
Reilly JP
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S11-7. PubMed ID: 10597119
[TBL] [Abstract][Full Text] [Related]
15. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
16. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
17. Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats.
Hagiwara T; Mukaisho K; Ling ZQ; Sugihara H; Hattori T
Dig Dis Sci; 2007 May; 52(5):1219-24. PubMed ID: 17357842
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis.
Mihara T; Adachi K; Komazawa Y; Yoshida M; Araki A; Maruyama R; Furuta K; Ishihara S; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2005 May; 20(5):682-7. PubMed ID: 15853979
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis.
Ligumsky M; Lysy J; Siguencia G; Friedlander Y
J Clin Gastroenterol; 2001 Jul; 33(1):32-5. PubMed ID: 11418787
[TBL] [Abstract][Full Text] [Related]
20. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
Kyzekova J; Mour J
Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
